Sanara MedTech Statistics
Total Valuation
Sanara MedTech has a market cap or net worth of $192.47 million. The enterprise value is $224.93 million.
Important Dates
The last earnings date was Wednesday, November 12, 2025, before market open.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Sanara MedTech has 8.94 million shares outstanding. The number of shares has increased by 1.70% in one year.
| Current Share Class | 8.94M |
| Shares Outstanding | 8.94M |
| Shares Change (YoY) | +1.70% |
| Shares Change (QoQ) | +3.81% |
| Owned by Insiders (%) | 31.06% |
| Owned by Institutions (%) | 18.56% |
| Float | 3.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 18.79 |
| PS Ratio | 1.84 |
| Forward PS | 1.70 |
| PB Ratio | 31.66 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 51.01 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.21 |
| EV / EBITDA | 39.09 |
| EV / EBIT | 156.44 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 7.72.
| Current Ratio | 1.80 |
| Quick Ratio | 1.56 |
| Debt / Equity | 7.72 |
| Debt / EBITDA | 7.54 |
| Debt / FCF | n/a |
| Interest Coverage | 0.23 |
Financial Efficiency
Return on equity (ROE) is -27.75% and return on invested capital (ROIC) is 1.44%.
| Return on Equity (ROE) | -27.75% |
| Return on Assets (ROA) | 1.13% |
| Return on Invested Capital (ROIC) | 1.44% |
| Return on Capital Employed (ROCE) | 2.68% |
| Revenue Per Employee | $722,536 |
| Profits Per Employee | -$265,896 |
| Employee Count | 141 |
| Asset Turnover | 1.28 |
| Inventory Turnover | 2.47 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.48% in the last 52 weeks. The beta is 1.18, so Sanara MedTech's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -39.48% |
| 50-Day Moving Average | 26.72 |
| 200-Day Moving Average | 29.60 |
| Relative Strength Index (RSI) | 42.36 |
| Average Volume (20 Days) | 69,067 |
Short Selling Information
The latest short interest is 222,932, so 2.49% of the outstanding shares have been sold short.
| Short Interest | 222,932 |
| Short Previous Month | 196,883 |
| Short % of Shares Out | 2.49% |
| Short % of Float | 6.17% |
| Short Ratio (days to cover) | 4.47 |
Income Statement
In the last 12 months, Sanara MedTech had revenue of $101.88 million and -$37.49 million in losses. Loss per share was -$4.36.
| Revenue | 101.88M |
| Gross Profit | 93.98M |
| Operating Income | 1.44M |
| Pretax Income | -6.33M |
| Net Income | -37.49M |
| EBITDA | 5.75M |
| EBIT | 1.44M |
| Loss Per Share | -$4.36 |
Full Income StatementBalance Sheet
The company has $14.94 million in cash and $47.39 million in debt, giving a net cash position of -$32.45 million or -$3.63 per share.
| Cash & Cash Equivalents | 14.94M |
| Total Debt | 47.39M |
| Net Cash | -32.45M |
| Net Cash Per Share | -$3.63 |
| Equity (Book Value) | 6.14M |
| Book Value Per Share | 0.69 |
| Working Capital | 13.87M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $3.77 million and capital expenditures -$4.62 million, giving a free cash flow of -$842,048.
| Operating Cash Flow | 3.77M |
| Capital Expenditures | -4.62M |
| Free Cash Flow | -842,048 |
| FCF Per Share | -$0.09 |
Full Cash Flow StatementMargins
Gross margin is 92.25%, with operating and profit margins of 1.41% and -36.80%.
| Gross Margin | 92.25% |
| Operating Margin | 1.41% |
| Pretax Margin | -6.21% |
| Profit Margin | -36.80% |
| EBITDA Margin | 5.65% |
| EBIT Margin | 1.41% |
| FCF Margin | n/a |
Dividends & Yields
Sanara MedTech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.70% |
| Shareholder Yield | -1.70% |
| Earnings Yield | -19.48% |
| FCF Yield | -0.44% |
Analyst Forecast
The average price target for Sanara MedTech is $41.00, which is 89.82% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $41.00 |
| Price Target Difference | 89.82% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 10, 2019. It was a reverse split with a ratio of 1:100.
| Last Split Date | May 10, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
Sanara MedTech has an Altman Z-Score of 2.89 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.89 |
| Piotroski F-Score | 5 |
